Pharmaceutical products for FDA CDER research studies
Pharmaceutical Products for CDER Research Studies - IDIQ — Solicitation 029067a9d94747c3bce74a8dca61bb82, issued by Federal (Maryland place-of-performance).
In plain English
The FDA's Center for Drug Evaluation and Research (CDER) awarded a $4 million indefinite-delivery contract to supply pharmaceutical products for ongoing research studies. This multi-year IDIQ contract supports FDA's drug evaluation and research operations. The work is performed in North Carolina.
Key facts
- Issuing agency
- Federal (Maryland place-of-performance)
- Solicitation number
- 029067a9d94747c3bce74a8dca61bb82
- Type
- Award Notice
- Posted
- Sep 11, 2026
- Place of performance
- NC, 27560
Award
Awarded to WE PHARMA, INC. on Sep 11, 2026.
Full award intelligence — SledAtlas Pro
- Winning vendor's full award history — federal and Maryland local
- Recompete alert when this contract comes back around
- Award trends for this agency and category
Official description
Solicitation #75F40126D00023. Issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF › FOOD AND DRUG ADMINISTRATION › FDA OFFICE OF ACQ GRANT SVCS. NAICS 325412. Product/Service Code 6505. Place of performance: NC, 27560. Awarded to WE PHARMA, INC. for $4,000,000 on 2026-09-11.
Respond to this bid
This solicitation is administered by the issuing agency through its samgov procurement portal. Submission happens there, not on SledAtlas.
The direct link to the source posting is included with a free SledAtlas account — coming soon. Join the waitlist on the home page to get access at launch.